Is This OK Under PhRMA’s New Code?
I'm getting some pretty amusing responses to the following question asked in my Survey regarding PhRMA's New Code on Interactions with Physicians:The code document has a Q&A section that lists several...
FDA Intern Gets Her Bonus!
According to a CBS News story -- "FDA Execs Reap Lavish Bonuses" -- 28 senior FDA executives took in a combined $1 million in bonuses last year."They've done such a miserable...
“Candid Camera” Research Into Physician-Patient Interactions
The folks at MBS/Vox, part of CommonHealth, "a research-based consultancy specializing in the physician-patient dialogue," are at it again with their "candid camera" doctor's office research.You may remember CommonHealth's claim that...
Is This Permitted Under New Code of Interactions with Health Professionals?
I'm getting some pretty good responses to my Online Survey regarding PhRMA's New Code of Interactions with Health Professionals. See and take the survey here.Results of this survey will be used...
Pharma Marketers Sometimes View Patients Merely as Symptoms to be Treated
"...a feature common to most drug ads: they leave you confused about the information," says Kate Pickert, a Time Magazine reporter and author of the article "Do Consumers Understand Drug Ads?"I'd...
What’s Your Opinion of PhRMA’s New Code?
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) Board of Directors adopted measures to enhance the PhRMA Code on Interactions with Healthcare Professionals.Among its changes, the revised Code (learn more...
Pharma Vendor and Ad Agency Diversity: All Talk, No Action?
Craig DeLarge, Associate Director, eMarketing & Relationship Marketing at Novo Nordisk Inc., was a featured speaker at the 4th Annual Pharma Networking Dinner Reception that I hosted at the Princeton, NJ...
A Novel Approach to Communicating with Physicians
That's the title of a Pharma Marketing News article I wrote some time ago about "a patent-pending technology" developed by a company called MagicMedia Communications. It offers a novel way for...
AAP Guidelines May Help Extend the Patent Life of Lipitor
Pfizer is searching for a way to maintain the LIPITOR franchise and the American Academy of Pediatrics (AAP) may have just supplied the solution: A new indication for the treatment of...
FDA Intern vs. Inebriated Advisory Committee Antagonist
Yes, it's FDA Intern! Strange visitor from an Ivy League school who came to FDA with powers and ability far beyond those of Janet Woodcock or even FDA commish Andy von...
